Tumor‐associated macrophages in liver cancer: from mechanisms to therapy

K Cheng, N Cai, J Zhu, X Yang, H Liang… - Cancer …, 2022 - Wiley Online Library
Multidimensional analyses have demonstrated the presence of a unique tumor
microenvironment (TME) in liver cancer. Tumor‐associated macrophages (TAMs) are …

Macrophage-based approaches for cancer immunotherapy

NR Anderson, NG Minutolo, S Gill, M Klichinsky - Cancer research, 2021 - AACR
Adoptive cell therapy with genetically modified T cells has generated exciting outcomes in
hematologic malignancies, but its application to solid tumors has proven challenging. This …

Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)

CN Gruber, RS Patel, R Trachtman, L Lepow, F Amanat… - Cell, 2020 - cell.com
Initially, children were thought to be spared from disease caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). However, a month into the epidemic, a novel …

Major pathways involved in macrophage polarization in cancer

C Kerneur, CE Cano, D Olive - Frontiers in immunology, 2022 - frontiersin.org
Macrophages play an important role in tissue homeostasis, tissue remodeling, immune
response, and progression of cancer. Consequently, macrophages exhibit significant …

Tumor immune microenvironment during epithelial–mesenchymal transition

M Taki, K Abiko, M Ukita, R Murakami, K Yamanoi… - Clinical Cancer …, 2021 - AACR
Epithelial–mesenchymal transition (EMT) has been shown to play a critical role in tumor
development from initiation to metastasis. EMT could be regarded as a continuum, with …

Targeting macrophages: therapeutic approaches in cancer

L Cassetta, JW Pollard - Nature reviews Drug discovery, 2018 - nature.com
Infiltration of macrophages in solid tumours is associated with poor prognosis and correlates
with chemotherapy resistance in most cancers. In mouse models of cancer, macrophages …

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy

MA Cannarile, M Weisser, W Jacob, AM Jegg… - … for immunotherapy of …, 2017 - Springer
The tumor-permissive and immunosuppressive characteristics of tumor-associated
macrophages (TAM) have fueled interest in therapeutically targeting these cells. In this …

The M-CSF receptor in osteoclasts and beyond

SH Mun, PSU Park, KH Park-Min - Experimental & molecular medicine, 2020 - nature.com
Colony-stimulating factor 1 receptor (CSF1R, also known as c-FMS) is a receptor tyrosine
kinase. Macrophage colony-stimulating factor (M-CSF) and IL-34 are ligands of CSF1R …

Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation

I Kaplanov, Y Carmi, R Kornetsky… - Proceedings of the …, 2019 - National Acad Sciences
Interleukin-1β (IL-1β) is abundant in the tumor microenvironment, where this cytokine can
promote tumor growth, but also antitumor activities. We studied IL-1β during early tumor …

GM-CSF: from growth factor to central mediator of tissue inflammation

B Becher, S Tugues, M Greter - Immunity, 2016 - cell.com
The granulocyte-macrophage colony-stimulating factor (GM-CSF) was initially classified as a
hematopoietic growth factor. However, unlike its close relatives macrophage CSF (M-CSF) …